ClinicalTrials.Veeva

Menu

Inpatient COVID-19 Lollipop Study

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Terminated

Conditions

COVID-19
Diagnostic Test

Treatments

Device: Lollipop

Study type

Interventional

Funder types

Other

Identifiers

NCT05801341
SMPH\PEDIATRICS\INFECT DIS (Other Identifier)
Protocol Version 4/4/2023 (Other Identifier)
2023-0290

Details and patient eligibility

About

This study is being done to see if collecting saliva samples with a "lollipop" collection method works as well as nasopharyngeal samples for COVID-19 polymerase chain reaction (PCR) testing. 225 COVID-positive participants aged 4 years and above admitted to a hospital in the Madison, Wisconsin metropolitan area will be enrolled over a 6 month period.

Full description

This is a prospective quantitative study evaluating the utility of a novel method of saliva collection for COVID-19 testing.

Primary Objective

  • To determine the performance characteristics of oral lollipop swabs compared to Nasal Pharyngeal (NP) swabs for diagnosing COVID-19 via PCR molecular testing.

Secondary Objectives

  • To identify clinical characteristics of patients when there are discordant results for NP and oral lollipop test results.

Enrollment

17 patients

Sex

All

Ages

4+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Ability to understand and the willingness to provide verbal informed consent, if 18 years or older. If 4-17 years old, ability to understand and the willingness to provide verbal assent, plus have a parent or legal guardian present who can provide verbal informed consent.
  • Willing to comply with all study procedures and be available for the duration of the study.
  • Admitted to UW Health University Hospital or UW Health Kids American Family Children's Hospital.
  • Individuals at least 4 years of age.
  • Verified COVID-19 according to positive NP PCR test criteria.
  • Enroll within 47 hours of the diagnostic NP swab; lollipop swab collected within 48 hours of the diagnostic NP swab.
  • Either personally able or have a parent or legal guardian able to verbally answer questions in English about clinical symptoms, exposures, and other health and demographic information.

Exclusion criteria

  • Unable to suck on a swab.
  • Previous participation in this study.
  • Require translation services for medical care.
  • Not suitable for study participation due to other reasons at the discretion of the investigators or their designee.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

17 participants in 1 patient group

COVID-19 Positive Participants
Experimental group
Description:
Determined by NP PCR test
Treatment:
Device: Lollipop

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Cassandra Nelson, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems